Claritus Pharmaceuticals Inc. (CLAZF)

[StockWatch45]

IMO this is a very solid play with an eye toward 2020 being the breakout year. I don't expect much of anything prior to that time period - but I like to think of it this way: This company is developing a new, patented, prodrug to both prevent and treat GVHD. They are approaching 200M share count. It is not unheard of for large drug companies to buy developmental companies new drugs for 3-7 Billion dollars.
If a large company buys this one in 3 years for 2B, it works out to about $10/share at 200M shares. If that should occur -- and I know it is a very big IF -- anyone who bought shares for $0.12-$0.20 cents is going to be very happy!

All just my own opinion. Do your own DD, make your own decisions.